Top Institutions in Ophthalmology - Glaucoma
Institutions leading in glaucoma research typically conduct multi-phase clinical trials, develop innovative drug therapies, and pioneer surgical techniques. Their expertise is demonstrated through extensive clinical trial sponsorship, translational research, and collaboration with industry partners.
-
#1
Stanford University
Stanford, CA
Stanford leads in glaucoma research with multiple ongoing clinical trials investigating novel therapies such as topical insulin and encapsulated cell therapy for neuroprotection and vision restoration. Their integration of cutting-edge translational research and clinical application positions them at the forefront of glaucoma innovation.
-
#2
Bausch + Lomb Inc.
Rochester, NY
Bausch + Lomb is a global leader in ophthalmic pharmaceutical development, conducting large-scale clinical trials such as the Phase 2 study comparing BL1107 eye drops to timolol for glaucoma treatment, demonstrating their expertise in drug efficacy and safety evaluation.
-
#3
University of Maryland, Baltimore
Baltimore, MD
The University of Maryland focuses on vascular and autoregulatory mechanisms in glaucoma, conducting clinical studies to establish retinal blood flow autoregulation as a biomarker for early disease detection, highlighting their strength in pathophysiological research.
-
#4
Glaukos Corporation
San Clemente, CA
Glaukos is a leader in developing minimally invasive surgical devices for glaucoma management, sponsoring clinical trials evaluating the standalone iStent infinite and iDose TR implants, which offer alternatives to traditional filtering surgery.
-
#5
Insight Eyecare Specialties, Inc dba Vision Source Eyecare
Unknown, Unknown
Insight Eyecare Specialties conducts focused clinical trials on pharmacologic agents such as brimonidine tartrate to evaluate ocular surface effects in glaucoma patients, contributing to therapeutic optimization.